Williams Paul Anthony (CIK 1961994) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell EBS (3,000 shares), Sell EBS (694 shares), Buy EBS (100,111 shares), Sell EBS (4,000 shares), Sell EBS (9,397 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 3,000 | $25,200 |
| 2026-06-10 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 694 | $5,552 |
| 2026-05-01 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Buy | 100,111 | $0 |
| 2026-04-03 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 4,000 | $33,760 |
| 2026-03-05 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 9,397 | $79,311 |
| 2026-03-03 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 116 | $945 |
| 2026-02-10 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 8,655 | $94,513 |
| 2026-02-10 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 1,022 | $11,160 |
| 2025-06-10 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 464 | $3,076 |
| 2025-03-10 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Buy | 62,500 | $0 |
| 2025-03-04 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 382 | $2,857 |
| 2025-03-04 | Emergent BioSolutions Inc. (EBS) | SVP, Products Business | Sell | 116 | $868 |
Source: SEC Form 4 filings · as of 2026-07-02